Click here for more information about laboratory operations and procedures
If you have additional questions regarding this test, please call: 415-353-1667
|Test group||Oncology FISH|
|Performed by||Medical Genomics - Molecular Diagnostics|
|In House Availability||Run 2x per week, Monday & Wednesday, day shift only|
|Method||Fluorescent in-situ hybridization (FISH)|
|Collection Instructions||For UCSF Samples (from remote sites) Click here for sample collection instructions
For NON-UCSF Samples Click here for Requisition form & Account set-up instructions. Note we only do institutional billing.
|Sample type||Formalin-fixed, paraffin-embedded tissue on three (3) unstained slides (5 microns thick) on charged glass. One adjacent hematoxylin and eosin stained (H&E) slide should also be included. Slides should be labeled with pathology case number and block identification.|
|Preferred volume||3 unstained slides (5 micron thick sections)|
|Min. Volume||1 unstained slides (5 micron thick sections)|
|Units||Ratio of MYCN to CEP2 signals|
|Normal range||1.09 +/- 0.21|
|Stability||Slides are stable indefinitely at room temperature|
|Turn around times||10-14 days|
|Additional information||An interpretation of this test by a laboratory physician will automatically be performed and billed for separately.
MYCN (n-myc) amplification by FISH is designed to detect gain of the MYCN locus in tumors. Amplification of MYCN has been associated with poor prognosis in Neuroblastoma and Medulloblastoma.
The clinical interpretation of this test should be evaluated within the context of the patient's medical history, other diagnostic tests, and the histologic and immunohistochemical features of the tumor.
The test was validated by UCSF Clinical Laboratories to confirm performance characteristics, in compliance with current guidelines for clinical implementation.
|CPT coding||88368 x2|
|LDT or Mod FDA?||Yes|
|Last Updated||1/22/2014 9:00:10 AM|